Cost Becomes Bigger Question in Treating Heart Disease

Published November 13, 2012

Cost becomes bigger question in treating heart disease

Filed under: drug treatment news 2012

The 2012 meeting, held last week in Los Angeles, included several dual presentations with companion studies on the economic impact of a drug or therapy as well as its safety and effectiveness. "We have an unsustainable economic model in healthcare …
Read more on Reuters Africa

EU Nod for Novartis' Votubia – Analyst Blog

Filed under: drug treatment news 2012

The drug is also approved in the US and EU for the treatment of advanced renal cell carcinoma (kidney cancer) after the failure of treatment with Pfizer Inc. 's ( PFE ) Sutent (sunitinib) or Onyx Pharmaceuticals, Inc. 's ( ONXX ) Nexavar (sorafenib …
Read more on NASDAQ